Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Von Hippel-Lindau disease.

Toshiaki Sano1, Hidehisa Horiguchi

  • 1Department of Pathology, University of Tokushima School of Medicine, Tokushima 770-8503, Japan. sano@basic.med.tokushima-u.ac.jp

Microscopy Research and Technique
|January 23, 2003
PubMed
Summary

Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by VHL gene mutations. Inactivation of the VHL gene promotes tumor growth and blood vessel formation, leading to early-onset, multifocal tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Ovarian Seromucinous Borderline Tumor With a Predominant Serous Component Suggesting Serous Borderline Tumor With Mucinous Differentiation.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2026
Same author

Neurocysticercosis in a Japanese woman with lung cancer who repeatedly visited endemic countries.

BMC infectious diseases·2021
Same author

Idiopathic giant-cell granuloma of the pituitary with unusual clinical and histological features.

Endocrine pathology·2020
Same author

Plurihormonality in neuroendocrine tumors.

Endocrine pathology·2020
Same author

Localized adiposity of the thyroid, clinically mimicking an adenoma.

Endocrine pathology·2020
Same author

Deoxycorticosterone-secreting adrenocortical carcinoma.

Endocrine pathology·2020

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Von Hippel-Lindau (VHL) disease is an inherited disorder characterized by the development of multiple tumors.
  • Germline mutations in the VHL tumor suppressor gene cause VHL disease.
  • VHL-associated tumors include hemangioblastomas, clear cell renal cell carcinomas, and pheochromocytomas.

Purpose of the Study:

  • To elucidate the role of the VHL gene in tumor development.
  • To understand the molecular mechanisms underlying VHL-associated tumorigenesis.
  • To explore genotype-phenotype correlations in VHL disease.

Main Methods:

  • Genetic analysis of VHL gene mutations.
  • Histopathological examination of VHL-associated tumors.
  • Investigation of VHL protein function in regulating gene expression and angiogenesis.

Main Results:

  • VHL gene inactivation leads to overexpression of vascular endothelial growth factor (VEGF), promoting tumor hypervascularization.
  • Loss of VHL protein function contributes to uncontrolled cell growth and cell cycle dysregulation.
  • Distinct VHL gene mutation patterns correlate with specific clinical manifestations (genotype-phenotype correlations).

Conclusions:

  • Inactivation of the VHL gene is a critical driver of angiogenesis and tumorigenesis in VHL disease.
  • Understanding VHL gene function provides insights into sporadic tumor development.
  • Genotype-phenotype correlations are important for predicting clinical outcomes in VHL patients.

Related Experiment Videos